Bull's eye maculopathy in an HIV-positive patient receiving ritonavir

Lemuel Non; Abdallah Jeroudi; Bradley T. Smith; Shadi Parsaei

doi:10.3851/IMP3007

Bull's eye maculopathy in an HIV-positive patient receiving ritonavir

Lemuel Non
, Abdallah Jeroudi
, Bradley T. Smith
, Shadi Parsaei

Division of Infectious Diseases

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.

Original language	English
Pages (from-to)	365-367
Number of pages	3
Journal	Antiviral Therapy
Volume	21
Issue number	4
DOIs	https://doi.org/10.3851/IMP3007
State	Published - 2016

Access to Document

10.3851/IMP3007

Cite this

@article{ce6bf1673ffe485d84c9b9c4aeb4d678,

title = "Bull's eye maculopathy in an HIV-positive patient receiving ritonavir",

abstract = "Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.",

author = "Lemuel Non and Abdallah Jeroudi and Smith, \{Bradley T.\} and Shadi Parsaei",

note = "Publisher Copyright: {\textcopyright}2016 International Medical Press.",

year = "2016",

doi = "10.3851/IMP3007",

language = "English",

volume = "21",

pages = "365--367",

journal = "Antiviral Therapy",

issn = "1359-6535",

number = "4",

}

TY - JOUR

T1 - Bull's eye maculopathy in an HIV-positive patient receiving ritonavir

AU - Non, Lemuel

AU - Jeroudi, Abdallah

AU - Smith, Bradley T.

AU - Parsaei, Shadi

PY - 2016

Y1 - 2016

N2 - Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.

AB - Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.

UR - https://www.scopus.com/pages/publications/84984677482

U2 - 10.3851/IMP3007

DO - 10.3851/IMP3007

M3 - Article

C2 - 26555254

AN - SCOPUS:84984677482

SN - 1359-6535

VL - 21

SP - 365

EP - 367

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 4

ER -

Bull's eye maculopathy in an HIV-positive patient receiving ritonavir

Abstract

Access to Document

Other files and links

Fingerprint

Cite this